Plunkett Research Online: CASI Pharmaceuticals Inc

CASI PHARMACEUTICALS INC (CASI:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

CASI Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that develops multi-mechanism oncology drugs to treat cancer and inflammatory disease by targeting diseased cells and their nourishing blood vessels. The firm’s internally-developed product candidate, and its only product under a.....



CASI Pharmaceuticals Inc
Ticker: CASI
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 240 864-2600
Fax: 240 864-2601
Address: 9620 Medical Center Drive
Suite 300
Rockville, MD 20850 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Angiogenesis
Drugs-Cancer & Rheumatoid Arthritis
ContactsDescription
Ken RenCEO/Director
Wei-Wu HeChairman of the Board/Director
See More
CASI Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that develops multi-mechanism oncology drugs to treat cancer and inflammatory disease by targeting diseased cells and their nourishing blood vessels. The firm’s internally-developed product candidate, and its only product under a.....See More See More

Auditor: CohnReznick LLP
Legal Advisor: Arnold & Porter LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
ENMD-2076
Spectrum Pharmaceuticals Inc
ZEVALIN
MARQIBO
EVOMELA
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: